Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: Blackbird recovers after director buying and Phoenix Copper bond issue

AIM movers: Zinnwald Lithium premium subscription and ex-dividends

AIM movers: Pathfinder Minerals finalises disposal and Anpario profit slump

AIM Movers: Manx Financial dividend hike and Eqtec falls below placing price

AIM movers: Third Xeros Technology licence and discounted Agriterra placing

New Aquis admission: Agglomeration plans for MBH Corporation

Aquis weekly movers: NFT Investments overhang sold

Tip update: Cordel’s Amtrak contract

AIM weekly movers: Potential buyers for Condor Gold project

AIM movers: Verditek supply agreement and Circle Property distribution

Restore to focus on organic growth

AIM movers: California contract for Kooth and ex-dividends

AIM movers: Amtrak contract for Cordel and Yu Group profit-taking continues

Clareti operational gearing for Gresham Technologies

AIM movers: Blue Star Capital investee launch and profit-taking for Yu Group

Why companies left AIM in February 2023

Dekel Agri-Vision volumes could improve in March

Further progress at MTI Wireless

M7 Box+ REIT set to join IPSX in April

AIM movers: Condor Gold progresses La India sale and Aferian continues fall

Aquis weekly movers: Six companies with rising share prices

Town Centre discount

UK companies that have relationships with Silicon Valley Bank

AIM weekly movers: Celadon Pharmaceuticals share price recovery

AIM movers: Tintra subscription and Aferian hit by destocking

AIM movers: Atlantic Lithium refutes short-selling claims and ex-dividends

Flat revenues at Somero Enterprises

Cloud accelerates Netcall progress

Breedon plans premium move

AIM movers: Time Finance gains momentum and Midatech Pharma to leave AIM

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020